The IBCSG has always been dedicated to innovative clinical research designed to improve the prognosis of women with breast cancer. Patients and investigators from five continents: Europe, Australia/ New Zealand, Africa, Asia, and North and South America, cooperate by participating in extensive clinical trials in the Adjuvant breast cancer setting. IBCSG has been a pioneer in research into combined hormonal therapy and chemotherapy, timing and duration of Adjuvant Therapies, and Quality of Life of breast cancer patients. IBCSG is part of Breast International Group(BIG).
Originator(s):
IBCSG
Resource added in:
02/10/2002
Objective:
The mission of IBCSG is to make progress in the prevention and treatment of breast cancer through the cooperation of centers around the world in breast cancer clinical trials. This website was designed to facilitate communication with the cooperative research group organization members.
Available languages:
English, French
Drug Therapy, Radiotherapy, General Surgery, Recurrence, Classification, Neoplasms, Drug Therapy, Chemotherapy, Adjuvant, Antineoplastic Agents, Hormonal, Clinical Protocols, Research Design, Clinical Trials Data Monitoring Committees, Antineoplastic Combined Chemotherapy Protocols, Quality of Life, Research Groups, Neoplasmas de la Tiroides, Estadificación de Neoplasmas, recurrencia local del neoplasma, Neoplasmas de la Mama, Prevención, Ensayos Clínicos, Estudios Multicéntricos
Português
Español
